# PharmaCyte Biotech, Inc.: Form 8-K, filed Jul 21, 2022

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2022-07-21
- Accepted by EDGAR: Jul 21, 2022, 14:57 ET
- Period: 2022-07-21
- Accession: 0001683168-22-005063
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822005063/pharmacyte_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000168316822005063/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000168316822005063/pharmacyte_8k.htm

Filed Jul 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-005063. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
